Tuesday, May 3, 2016

Giant Consolidations: IMS/Quintiles to follow Payers, Hospitals, and Pharmas in Consolidation Bonanza

Articles on the ongoing rollup of physicians into hospital networks, hospitals into bigger networks, pharmas into mergers, and payers into mergers...are legion.   For an April 29, 2016 article at NYT, here.   

The healthcare information, R&D, and value measurement industry is gaining a colossus worth about $20B with the merger of Quintiles and IMS Health, announced on May 3.  For an article at MedCity News, here.   Writing in part:

Two heavyweights in healthcare and biopharma Big Data, IMS Health and Quintiles Transnational Holdings, are coming together in what the companies are calling a “merger of equals.” The all-stock transaction brings together companies with a combined enterprise value of upwards of $23 billion and current market capitalization of $17.6 billion.  “This combination addresses life-science companies’ most pressing needs: (1) to transform the clinical development of innovative medicines, (2) demonstrate the value of these medicines in the real world and (3) drive commercial success,” said Quintiles CEO Tom Pike.

For an acquisition that brought together a lab and a CRO, recall the $6B acquisition of Covance by Labcorp in early 2015.